ClinicalTrials.gg
Sign In

Carcinoma clinical trials

The registry lists 736 studies for Carcinoma across more than 10 countries. 149 are recruiting or about to start. 209 of them are mainly about Carcinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 57 narrower conditions too, such as Carcinoma, Hepatocellular: 14,696 studies, 3,930 open.

ClinicalTrials.gov finds 28,159 studies for Carcinoma. How that becomes 735 here

This page counts the studies the registry files under Carcinoma, and those it files under no condition that list Carcinomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 28,159Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −13,619Filed under a narrower condition, counted on its own pageCarcinoma, Hepatocellular 3,339 · Carcinoma, Renal Cell 1,786 · Squamous Cell Carcinoma of Head and Neck 1,755 · Carcinoma, Ovarian Epithelial 702 · Cholangiocarcinoma 629 · Nasopharyngeal Carcinoma 608 · 47 more
  3. −5,616List Carcinoma as a condition, but the registry did not file them under itMost often written as “Carcinoma, Non-Small-Cell Lung” (606), “Breast Carcinoma” (258), and “Colorectal Carcinoma” (202). The registry filed 937 of them under no condition at all, and the others under other conditions only, most often Carcinoma, Non-Small-Cell Lung (1,153) and Breast Neoplasms (639).
  4. −8,189Match it another way2,318 name it in the title, 482 in a keyword, and 5,389 by a synonym or other text the search reads.
  5. 735The count on this page

Get an email when these change. Save the Carcinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
346
Recruiting
115
Terminated
87
Status unknown
63
Active, not recruiting
56
Withdrawn
30

Phase

Phase 2
285
Phase 1
212
Phase 3
84
Phase 4
14
Early Phase 1
9

Where

United States
402
France
104
China
101
Spain
83
Canada
80
Italy
71

Who runs them

National Cancer Institute (NCI) (26) · Pfizer (23) · Novartis Pharmaceuticals (19) · AstraZeneca (17) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (13) · Amgen (10) · M.D. Anderson Cancer Center (10) · Eli Lilly and Company (9)

What is being tested here

Drugs under test in Carcinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin4623
Paclitaxel3326
Cemiplimab303
Anti-PD-1/Anti-VEGF Bispecific Antibody PF-08634404313
Cetuximab239
Pembrolizumab209
Cabozantinib226
Cyclophosphamide204
Toripalimab202
Oncolytic HSV-1 R130202

Drug classes tested here Immune checkpoint inhibitors 17 open · Tyrosine kinase inhibitors (TKIs) 13 open · Antimitotic agents 5 open · Antimetabolites 5 open · Antibody-drug conjugates (ADCs) 3 open

Coming up

25phase 3 studies under way
53studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 115 Carcinoma studies recruiting now, 92 (80%) set no upper age limit and 14 (12%) stop at 75 or younger. 11 (10%) take children under 18. 6 (5%) are for women only and 1 (1%) for men only; 4 (3%) take healthy volunteers.

Recruiting studies that take each age, of 115
AgeWomenMen
108 (7%)8 (7%)
18111 (97%)106 (92%)
30111 (97%)106 (92%)
40111 (97%)106 (92%)
50111 (97%)106 (92%)
65111 (97%)106 (92%)
75108 (94%)103 (90%)
8595 (83%)91 (79%)

Across all 736 studies, recruiting or not: 10% stop at 75 or younger and 3% at 65; 9% take children; 9% are for women only and 2% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Carcinoma studies take

Of 83 phase 2 interventional studies under Carcinoma, half reached primary completion within 54 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 146 mo30–92 · 70 studies36 mo22–68 · 41 studies—
Phase 1/258 mo39–93 · 40 studies——
Phase 254 mo31–88 · 83 studies—54 mo33–88 · 56 studies
Phase 350 mo44–82 · 35 studies——
Interventional, no phase43 mo32–63 · 29 studies——
Observational49 mo29–166 · 62 studies—49 mo29–114 · 50 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting4

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 736. Browse all 736 → or search them.